NASDAQ:NH - NantHealth Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.6211 -0.07 (-10.13 %)
(As of 12/17/2018 08:57 AM ET)
Previous Close$0.6877
Today's Range$0.6210 - $0.6876
52-Week Range$0.62 - $4.05
Volume137,981 shs
Average Volume127,290 shs
Market Capitalization$68 million
P/E Ratio-0.55
Dividend YieldN/A
NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Data processing & preparation
Current SymbolNASDAQ:NH
Previous SymbolNYSE:NH


Debt-to-Equity Ratio3.89
Current Ratio1.24
Quick Ratio1.23


Trailing P/E Ratio-0.55
Forward P/E Ratio-0.43
P/E GrowthN/A

Sales & Book Value

Annual Sales$86.68 million
Price / Sales0.78
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.78 per share
Price / Book0.35


EPS (Most Recent Fiscal Year)($1.12)
Net Income$-175,210,000.00
Net Margins-185.22%
Return on Equity-116.23%
Return on Assets-40.69%


Outstanding Shares109,490,000
Market Cap$68 million

NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) posted its earnings results on Thursday, November, 15th. The company reported ($0.89) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.74. The firm earned $22.29 million during the quarter, compared to analysts' expectations of $25 million. NantHealth had a negative return on equity of 116.23% and a negative net margin of 185.22%. View NantHealth's Earnings History.

When is NantHealth's next earnings date?

NantHealth is scheduled to release their next quarterly earnings announcement on Wednesday, March 13th 2019. View Earnings Estimates for NantHealth.

What price target have analysts set for NH?

3 Wall Street analysts have issued 12-month target prices for NantHealth's stock. Their predictions range from $4.50 to $5.00. On average, they anticipate NantHealth's stock price to reach $4.75 in the next year. This suggests a possible upside of 664.8% from the stock's current price. View Analyst Price Targets for NantHealth.

What is the consensus analysts' recommendation for NantHealth?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.

Has NantHealth been receiving favorable news coverage?

News articles about NH stock have been trending somewhat positive on Monday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. NantHealth earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:
  • Dr. Patrick Soon-Shiong FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 65)
  • Mr. Ronald Allen Louks, COO & Director (Age 53)
  • Mr. Paul A. Holt, Exec. Officer (Age 52)
  • Mr. Bob Petrou, Interim Chief Financial Officer (Age 46)
  • Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Who are NantHealth's major shareholders?

NantHealth's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (2.17%) and Vanguard Group Inc (0.59%). View Institutional Ownership Trends for NantHealth.

Which major investors are buying NantHealth stock?

NH stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc. and Vanguard Group Inc. View Insider Buying and Selling for NantHealth.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $0.6211.

How big of a company is NantHealth?

NantHealth has a market capitalization of $68 million and generates $86.68 million in revenue each year. The company earns $-175,210,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. NantHealth employs 494 workers across the globe.

What is NantHealth's official website?

The official website for NantHealth is

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]

MarketBeat Community Rating for NantHealth (NASDAQ NH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  393
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel